Xencor Newsroom

Barclays Maintains Xencor(XNCR.US) With Sell Rating, Maintains Target Price $22

Futu NewsNov 9 19:33

CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38

Futu NewsNov 8 22:36

A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $22 to $34

Futu NewsNov 8 21:16

Barclays Sticks to Its Sell Rating for Xencor (XNCR)

TipRanksNov 8 17:53

JP Morgan Maintains Overweight on Xencor, Raises Price Target to $28

BenzingaNov 8 01:57

RBC Capital Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $34

Futu NewsNov 7 20:33

TD Cowen Maintains Xencor(XNCR.US) With Buy Rating

Futu NewsNov 7 08:33

Xencor's Strategic Advancements and Promising Pipeline Drive Buy Rating

TipRanksNov 7 08:07

CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38

Futu NewsNov 6 21:31

Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Argenica Therapeutics Ltd (AU:AGN) and Bio-Rad Laboratories (BIO)

TipRanksOct 8 17:04

Xencor Analyst Ratings

BenzingaSep 26 22:55

RBC Capital Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $34

Futu NewsSep 26 19:33

Xencor (XNCR) Gets a Buy From RBC Capital

TipRanksSep 26 18:59

A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $27 to $38

Futu NewsSep 10 21:00

Leerink Partners Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $32

Futu NewsAug 22 13:32

Buy Rating Affirmed for Xencor on Promising XmAb819 Developments and Strong Strategic Position

TipRanksAug 22 12:39

Buy Rating Affirmed for Xencor Amid Strong Drug Pipeline and Financial Health

TipRanksAug 9 17:49

Wedbush Maintains Xencor(XNCR.US) With Buy Rating, Cuts Target Price to $34

Futu NewsAug 7 13:31

Xencor Price Target Maintained With a $31.00/Share by RBC Capital

Dow JonesAug 6 21:32

Xencor Analyst Ratings

BenzingaAug 6 21:22